Clinical safety and activity in a phase 1 trial of IPI-145, a potent inhibitor of phosphoinositide-3-Kinase-δ,γ, in patients with advanced hematologic malignancies Meeting Abstract
| Authors: | Flinn, I. W.; Horwitz, S. M.; Patel, M.; Younes, A.; Porter, J. R.; Sweeney, J.; Allen, K.; Kelly, P.; Kahl, B. S. |
| Abstract Title: | Clinical safety and activity in a phase 1 trial of IPI-145, a potent inhibitor of phosphoinositide-3-Kinase-δ,γ, in patients with advanced hematologic malignancies |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000314049600254 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.3663.3663 |
| Notes: | --- - Meeting Abstract: 3663 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
